Assessment of CD133-positive extracellular membrane vesicles in pancreatic cancer ascites and beyond

Med Mol Morphol. 2020 Mar;53(1):60-62. doi: 10.1007/s00795-019-00221-w. Epub 2019 Apr 5.

Authors

Christine A Fargeas¹, Jana Karbanová¹, Denis Corbeil²

Affiliations

¹ Tissue Engineering Laboratories, Biotechnology Center (BIOTEC) and Center for Molecular and Cellular Bioengineering (CMCB), Technische Universität Dresden, Tatzberg 47-49, 01307, Dresden, Germany.
² Tissue Engineering Laboratories, Biotechnology Center (BIOTEC) and Center for Molecular and Cellular Bioengineering (CMCB), Technische Universität Dresden, Tatzberg 47-49, 01307, Dresden, Germany. denis.corbeil@tu-dresden.de.

PMID: 30953194
DOI: 10.1007/s00795-019-00221-w

No abstract available

Keywords: Biomarker; CD133; Cancer; Ectosome; Exosome; Prominin-1.

Publication types

Letter

MeSH terms

AC133 Antigen / genetics*
AC133 Antigen / metabolism
Artifacts
Ascites / diagnosis
Ascites / genetics*
Ascites / metabolism
Ascites / pathology
Biomarkers, Tumor / genetics*
Biomarkers, Tumor / metabolism
Extracellular Vesicles / metabolism*
Extracellular Vesicles / pathology
Glycosylation
Humans
Immunohistochemistry / standards
Pancreas / metabolism
Pancreas / pathology
Pancreatic Neoplasms / diagnosis
Pancreatic Neoplasms / genetics*
Pancreatic Neoplasms / metabolism
Pancreatic Neoplasms / pathology
Phosphorylation
Protein Processing, Post-Translational*
Ubiquitination

Substances

AC133 Antigen
Biomarkers, Tumor
PROM1 protein, human